PMID: 22338146Feb 18, 2012Paper

Research advances in microRNA in pancreatic ductal adenocarcinoma

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
Chun-Kai YuJie Chen

Abstract

MicroRNA (miRNA), small non-coding RNA consisted of 19-24 nucleotides, are able to regulate gene expression at the post-transcriptional level. The aberrant expressions of miRNA have been found in various cancers and contribute to carcinogenesis by promoting the expression of proto-oncogenes or by inhibiting the expression of tumor suppressor genes. miRNA are related closely with the oncogenesis, progression, and prognosis of tumors. The discovery of the aberrant expression of miRNA in pancreatic ductal adenocarcinoma (PDA) and its target genes are helpful for the understanding of the pathogenesis of PDA and for the early diagnosis and prediction of this disease. In this paper, we summarize the recent research advances in miRNA expression in PDA and its target genes and discuss the potential role of miRNA in the diagnosis, and treatment of PDA.

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
Mylene SeuxNelson J Dusetti
Experimental Oncology
E G NikitinaV N Stegny
Digestive Diseases and Sciences
Fuyi TongShenlin Liu
Trends in Molecular Medicine
Ramiro GarzonCarlo M Croce
Current Pharmaceutical Design
Hung-Wei PanKuo-Wang Tsai
© 2022 Meta ULC. All rights reserved